Your generous year-end donation will be matched $1 for $1 DONATE
With the online publication of an opinion piece in the Journal of the American Medical Association, Drs. Laura J. Esserman, Ian M. Thompson, and Brian Reid have triggered a medical, scientific, and policy debate about the definition of “cancer” and strategies for diagnosis and treating cancer. The authors wrote for a working group that was […]
NCCS filed comments in support of proposed cancer care quality measures that will be utilized to assess the cancer care provided by the prospective payment system (PPS)-exempt cancer hospitals. In its comments, NCCS focused on the outcome measure that will assess the performance of PPS-exempt institutions in preventing inpatient admission or emergency department care for […]
The United States Supreme Court ruled unanimously on June 13, 2013, that human genes cannot be patented. In the case of Association for Molecular Pathology v. Myriad Genetics, Inc., the Court found that Myriad had not created anything when it isolated the BRCA genes. However, the Court also ruled that patents might be available for […]
In the Sunday, July 14, New York Times, Clifton Leaf offered a critical evaluation of clinical trials. In letters to the editor published in the Times on July 18, 2013, several writers rebutted Leaf and defended the clinical trials enterprise. John LaMattina writes in Forbes that Leaf has resorted to negativism in his review of […]
October 1, 2013 is rapidly approaching. That’s the beginning of open enrollment for insurance through state exchanges created to satisfy the Affordable Care Act (ACA). The new health policy brief from Health Affairs explains the different models for exchanges, including both state-based and federally affiliated. It also lays out upcoming implementation activities and challenges facing […]
Clifton Leaf, a cancer survivor and the author of “The Truth in Small Doses: Why We’re Losing the War on Cancer – and How to Win It”, writes in The New York Times about the challenges that exist in human drug trials and the impact of biological diversity on outcomes. Researchers are coming to understand […]
The Senate Appropriations Committee approved a fiscal year 2014 funding bill by a party-line vote of 16 to 14 on July 11, 2013. In his opening statement at subcommittee markup, Subcommittee Chair Tom Harkin explained the importance of increasing funding for the National Institutes of Health (NIH). The Senate bill includes $30.955 billion for NIH, […]
Shelley Fuld Nasso, NCCS Senior Director of Policy, was a panelist at the June 28, 2013, Food and Drug Administration (FDA) meeting on patient-focused lung cancer drug development. Ms. Fuld Nasso offered advice to FDA about strategies for incorporating patient needs and preferences in lung cancer drug development. She concentrated her remarks on the need […]
In an article in the AARP Magazine, Dr. Nancy Snyderman, Chief Medical Editor for NBC News, describes her experience treating Lindsay Nohr, a patient with tongue cancer, describing Lindsay as “my patient, my teacher.” Dr. Snyderman writes, “We can’t know then what we will come to realize later in life — that our professors are […]
Alexander Nazaryan writes about “World War Cancer” in The New Yorker. Nazaryan’s blog post is a review of a forthcoming book by Clifton Leaf, “The Truth in Small Doses: Why We’re Losing the War on Cancer,” but it also references several recent articles that assess progress in the war on cancer. Nazaryan offers an honest […]
Survivorship Champions is a program for all clinicians and researchers, both oncology and primary care, who are interested in improving survivorship care and primary care’s role in caring for cancer survivors.
The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.
NCCS represents the millions of Americans who share a common experience – living with, through and beyond a cancer diagnosis. By sharing your story of how you have been touched by cancer, you are supporting the national cancer survivorship movement.
Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action
National Coalition for Cancer Survivorship
8455 Colesville Road | Suite 930 | Silver Spring, MD 20910
info@canceradvocacy.org | (877) NCCS-YES
Privacy Policy | Terms and Conditions
Copyright © 1995-2024 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.
"*" indicates required fields
"*" indicates required fields
Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.
Founder
Northeast Regional Cancer Institute
“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”
—Karen M. Saunders
President, Northeast Regional Cancer Institute